Read More

Small-Cap Cancer Focused Theseus Pharmaceuticals Goes Private For Over $3.90/Share In Cash

Theseus Pharmaceuticals Inc (NASDAQ: THRX) on Friday, has entered into a definitive merger agreement whereby Concentra Biosciences LLC will acquire Theseus for a price per share of between $3.90 and $4.05 in cash, consisting of a base cash price of $3.90 per share and an addi

THRX

Read More

Cepton, Inc. Confirms Receipt of Indication Of Interest From Koito Manufacturing Co., Ltd. To Acquire 100% Of The Outstanding Shares Of The Company Not Already Owned By Koito

Cepton, Inc. ("Cepton" or the "Company") (NASDAQ:CPTN), a Silicon Valley innovator and leader in high performance lidar solutions, announced today that it has received a non-binding indication of interest from Koito

CPTN